Ideaya Biosciences has reported positive interim Phase 2 clinical trial data for darovasertib in neoadjuvant uveal melanoma, or UM, as well as a successful Type C meeting with the Food and Drug ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

State Surgeon General Joseph Ladapo spread anti-vaccine misinformation by telling Floridians to avoid mRNA vaccines. Vaccine ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

Since cutting the ribbon on its inaugural commercial-scale Smart Factory in Bridgewater earlier this year, the San ...

Low consumer demand scuppered a previous vaccine in the 1990s, but the situation is very different now. Cases of Lyme have ...

We recently published a list of 10 Best Innovative Stocks that Pay Dividends. In this article, we are going to take a look at ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

We recently compiled a list of the Best Future Stocks For The Long-Term. In this article, we will look at where Pfizer Inc.

The most recent COVID-19 vaccines from Moderna and Pfizer were approved by the FDA on Aug. 24, with the CDC recommending Americans get their updated shots ahead of the winter virus season. Amish ...